Ildong Pharmaceutical Co., Ltd.
KRX:249420.KS
12300 (KRW) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 155,949 | 152,149.525 | 151,099.707 | 151,084.261 | 149,530.646 | 154,085.31 | 146,057.623 | 151,934.145 | 163,633.354 | 162,497.273 | 159,649.718 | 142,703.885 | 142,514.552 | 141,644.269 | 133,268.92 | 138,763.647 | 146,817.092 | 137,510.4 | 138,753.961 | 121,793.49 | 129,779.005 | 136,658.24 | 129,236.946 | 130,926.617 | 128,240.822 | 125,700.57 | 119,039.346 | 113,559.007 | 127,962.658 | 112,452.687 | 106,676.463 | 122,228.089 | 79,115.69 |
| Cost of Revenue
| 0 | 95,461.526 | 93,968.203 | 98,195.869 | 99,703.955 | 98,405.012 | 91,953.221 | 96,828.08 | 102,832.18 | 101,567.005 | 100,143.842 | 90,327.441 | 84,856.19 | 83,445.878 | 82,063.592 | 81,201.616 | 85,292.387 | 71,494.152 | 85,443.051 | 81,281.81 | 69,215.323 | 68,763.136 | 65,851.848 | 64,419.149 | 63,337.275 | 61,969.73 | 59,026.164 | 57,828.318 | 64,260.998 | 56,086.226 | 56,244.981 | 63,368.079 | 40,679.494 |
| Gross Profit
| 155,949 | 56,688 | 57,131.504 | 52,888.392 | 49,826.691 | 55,680.298 | 54,104.402 | 55,106.064 | 60,801.174 | 60,930.268 | 59,505.876 | 52,376.444 | 57,658.361 | 58,198.391 | 51,205.329 | 57,562.031 | 61,524.705 | 66,016.248 | 53,310.909 | 40,511.681 | 60,563.682 | 67,895.104 | 63,385.098 | 66,507.468 | 64,903.547 | 63,730.84 | 60,013.182 | 55,730.689 | 63,701.66 | 56,366.461 | 50,431.482 | 58,860.011 | 38,436.196 |
| Gross Profit Ratio
| 1 | 0.373 | 0.378 | 0.35 | 0.333 | 0.361 | 0.37 | 0.363 | 0.372 | 0.375 | 0.373 | 0.367 | 0.405 | 0.411 | 0.384 | 0.415 | 0.419 | 0.48 | 0.384 | 0.333 | 0.467 | 0.497 | 0.49 | 0.508 | 0.506 | 0.507 | 0.504 | 0.491 | 0.498 | 0.501 | 0.473 | 0.482 | 0.486 |
| Reseach & Development Expenses
| 0 | 10,777.508 | 16,421.173 | 19,273.696 | 24,322.388 | 26,640.846 | 24,781.14 | 27,450.428 | 27,996.684 | 30,930.139 | 23,517.854 | 29,831.601 | 25,181.911 | 18,351.01 | 23,159.334 | 20,333.024 | 15,463.318 | 11,572.001 | 12,812.535 | 14,253.989 | 12,569.652 | 11,335.521 | 10,338.277 | 11,484.257 | 10,742.173 | 10,557.206 | 13,674.497 | 9,061.681 | 8,631.7 | 8,063.704 | 7,605.404 | 7,372.527 | 5,134.067 |
| General & Administrative Expenses
| 0 | 56,882.829 | 58,205.492 | 3,250.027 | 66,873.898 | 74,862.791 | 68,940.881 | 3,752.18 | 3,645.502 | 3,324.836 | 3,244.605 | 3,059.216 | 3,049.574 | 3,171.605 | 3,145.888 | 2,640.062 | 2,871.661 | 2,795.752 | 3,266.356 | 3,769.328 | 3,458.822 | 4,077.515 | 3,743.194 | 4,580.009 | 3,887.982 | 4,304.728 | 4,434.672 | 4,066.979 | 4,338.678 | 4,345.663 | 4,687.711 | 3,672.045 | 2,677.425 |
| Selling & Marketing Expenses
| 0 | -11,520.227 | -17,601.249 | 15,787.999 | 18,282.675 | 15,345.515 | 19,227.052 | 26,345.015 | 25,657.025 | 26,332.804 | 22,768.574 | 18,140.353 | 21,876.477 | 24,849.636 | 18,101.667 | 20,570.044 | 21,287.964 | 24,518.729 | 18,583.916 | 19,612.719 | 22,544.158 | 24,349.008 | 21,301.195 | 19,315.547 | 24,849.725 | 20,114.366 | 15,742.339 | 18,094.615 | 20,023.934 | 19,377.767 | 16,264.458 | 15,012.414 | 13,920.76 |
| SG&A
| 0 | 45,362.602 | 40,604.243 | 36,477.709 | 66,873.898 | 74,862.791 | 68,940.881 | 30,097.195 | 29,302.527 | 29,657.64 | 26,013.179 | 21,199.569 | 24,926.051 | 28,021.241 | 21,247.555 | 23,210.106 | 24,159.625 | 27,314.481 | 21,850.272 | 23,382.047 | 26,002.98 | 28,426.523 | 25,044.389 | 23,895.556 | 28,737.707 | 24,419.094 | 20,177.011 | 22,161.594 | 24,362.612 | 23,723.43 | 20,952.169 | 18,684.459 | 16,598.185 |
| Other Expenses
| 152,345 | -152,650 | -151,004 | 316.287 | -133,747.796 | -149,725.582 | -25,014.21 | 20,665.887 | 22,245.884 | 22,536.73 | 19,262.559 | 1,219.203 | 55.952 | 323.587 | 268.42 | 468.43 | 757.344 | 233.468 | 480.226 | 33.61 | -425.723 | 119.018 | 146.927 | 1,376.97 | -195.889 | 115.008 | 183.039 | 375.853 | 385.466 | 233.05 | 43.63 | 747.354 | 151.102 |
| Operating Expenses
| 152,345 | 56,140.11 | 57,025.416 | 55,751.405 | -66,873.898 | -74,862.791 | 68,707.811 | 78,213.51 | 79,545.095 | 83,124.509 | 68,793.592 | 69,759.706 | 72,759.949 | 66,517.751 | 64,780.829 | 63,242.454 | 55,665.727 | 58,519.655 | 54,353.212 | 58,393.758 | 60,475.982 | 59,545.243 | 55,313.109 | 56,597.464 | 60,863.175 | 56,077.479 | 53,273.677 | 50,299.922 | 52,722.995 | 50,379.361 | 47,467.148 | 48,430.099 | 34,073.743 |
| Operating Income
| 3,604 | 547.889 | 106.088 | -2,863.013 | -17,047.207 | -19,182.493 | -14,836.479 | -23,107.446 | -18,743.921 | -22,194.241 | -9,287.716 | -18,485.285 | -14,939.292 | -8,427.305 | -13,683.396 | -5,680.423 | 5,858.977 | 7,496.594 | -1,042.303 | -17,882.077 | 87.7 | 8,349.86 | 8,071.989 | 9,910.006 | 4,040.373 | 7,653.359 | 6,739.505 | 5,430.766 | 10,978.664 | 5,987.101 | 2,964.333 | 10,429.911 | 4,362.454 |
| Operating Income Ratio
| 0.023 | 0.004 | 0.001 | -0.019 | -0.114 | -0.124 | -0.102 | -0.152 | -0.115 | -0.137 | -0.058 | -0.13 | -0.105 | -0.059 | -0.103 | -0.041 | 0.04 | 0.055 | -0.008 | -0.147 | 0.001 | 0.061 | 0.062 | 0.076 | 0.032 | 0.061 | 0.057 | 0.048 | 0.086 | 0.053 | 0.028 | 0.085 | 0.055 |
| Total Other Income Expenses Net
| -10,990 | -2,924.428 | 2,393.576 | -6,794.69 | -28,948.989 | -4,827.274 | -2,103.373 | -16,884.876 | -4,186.677 | 92,370.889 | -117,738.331 | -111,583.428 | 6,237.869 | 18,877.385 | -2,084 | -8,779.44 | -5,766.191 | -542.963 | -1,268.305 | -10,329.373 | -8,463.815 | -1,232.787 | -1,323.925 | -9,897.168 | -1,303.792 | -654.353 | -578.655 | -1,622.822 | -1,706.876 | -709.887 | -899.352 | -306.238 | -471.891 |
| Income Before Tax
| -7,386 | -1,907.257 | 2,489.462 | -9,671.768 | -45,996.196 | -24,009.767 | -14,594.639 | -40,043.398 | -22,930.598 | 70,176.648 | -127,026.047 | -127,186.302 | -8,701.423 | 10,450.08 | -15,767.396 | -14,459.864 | 92.786 | 6,953.631 | -2,310.608 | -28,211.45 | -8,376.115 | 7,205.079 | 6,748.064 | 235.632 | 3,042.696 | 6,999.006 | 6,160.85 | 3,807.944 | 9,271.788 | 5,277.214 | 2,064.981 | 10,123.673 | 3,890.563 |
| Income Before Tax Ratio
| -0.047 | -0.013 | 0.016 | -0.064 | -0.308 | -0.156 | -0.1 | -0.264 | -0.14 | 0.432 | -0.796 | -0.891 | -0.061 | 0.074 | -0.118 | -0.104 | 0.001 | 0.051 | -0.017 | -0.232 | -0.065 | 0.053 | 0.052 | 0.002 | 0.024 | 0.056 | 0.052 | 0.034 | 0.072 | 0.047 | 0.019 | 0.083 | 0.049 |
| Income Tax Expense
| 2,006 | 2,266.707 | 4,396.759 | -10,464.591 | 503.398 | 423.201 | -3,773.691 | 13,939.773 | -6,053.604 | 19,961.774 | -5,501.788 | -32,916.429 | -3,274.922 | -1,159.889 | -2,885.333 | 4,463.364 | -813.09 | 706.438 | -1,061.608 | -7,658.05 | -3,558.554 | 1,040.316 | 985.448 | 3,001.149 | -91.94 | 822.689 | -14.405 | -452.581 | 1,349.979 | -30.973 | -285.54 | 1,389.616 | 45.927 |
| Net Income
| -9,392 | -3,239.175 | -833.322 | 1,415.996 | -46,022.791 | -23,906.63 | -10,820.948 | -53,983.171 | -16,876.994 | 50,481.639 | -121,524.259 | -93,736.057 | -4,697.038 | 11,609.968 | -12,882.063 | -18,923.228 | 905.876 | 6,247.192 | -1,249 | -20,553.401 | -4,817.562 | 6,164.763 | 5,762.616 | -2,765.517 | 3,134.635 | 6,176.317 | 6,175.255 | 4,260.525 | 7,921.809 | 5,308.187 | 2,350.521 | 8,734.057 | 3,844.636 |
| Net Income Ratio
| -0.06 | -0.021 | -0.006 | 0.009 | -0.308 | -0.155 | -0.074 | -0.355 | -0.103 | 0.311 | -0.761 | -0.657 | -0.033 | 0.082 | -0.097 | -0.136 | 0.006 | 0.045 | -0.009 | -0.169 | -0.037 | 0.045 | 0.045 | -0.021 | 0.024 | 0.049 | 0.052 | 0.038 | 0.062 | 0.047 | 0.022 | 0.071 | 0.049 |
| EPS
| -498.55 | -115.96 | -29.83 | 50.69 | -1,710.92 | -892.53 | -403.99 | -2,015.4 | -630.08 | 1,885 | -4,862.14 | -3,941.03 | -197 | 488 | -542 | -795.63 | 38 | 262 | -52 | -863.97 | -193.33 | 251.43 | 230.48 | -116.23 | 125.17 | 247.62 | 246.71 | 179.05 | 317.75 | 212.99 | 94.37 | 366.13 | 169.22 |
| EPS Diluted
| -498.55 | -115.96 | -29.83 | 50.69 | -1,710.92 | -892.53 | -403.99 | -2,015.4 | -630.08 | 1,884.68 | -4,862.1 | -3,940.92 | -354 | 128 | -542 | -795.58 | 38 | 262 | -52 | -863.97 | -193.33 | 251.43 | 230.48 | -116.23 | 125.17 | 247.62 | 246.71 | 179.05 | 317.75 | 212.99 | 94.37 | 366.13 | 169.22 |
| EBITDA
| 3,604 | 57,899.636 | 6,385.694 | -298.717 | -33,642.279 | -13,273.736 | -4,014.355 | -29,332.78 | -13,439.67 | 79,443.377 | -117,161.317 | -116,890.06 | 1,468.86 | 20,596.909 | -6,511.848 | -6,383.431 | 12,446.722 | 14,585.904 | 5,847.992 | -19,952.263 | -85.668 | 15,407.59 | 15,087.462 | 15,601.393 | 9,699.6 | 13,103.045 | 12,350.753 | 10,384.953 | 15,530.248 | 10,511.773 | 7,380.334 | 15,665.485 | 4,839.357 |
| EBITDA Ratio
| 0.023 | 0.047 | 0.042 | 0.025 | 0.333 | 0.361 | 0.37 | -0.093 | -0.073 | -0.095 | -0.012 | -0.068 | -0.051 | -0.006 | -0.044 | 0.008 | 0.09 | 0.108 | 0.047 | -0.086 | 0.048 | 0.114 | 0.119 | 0.134 | 0.078 | 0.11 | 0.106 | 0.094 | 0.125 | 0.096 | 0.07 | 0.128 | 0.061 |